# Immunic (IMUX) — Earnings

IMUX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/imux/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.80 |
| EPS estimate | −$1.16 |
| EPS surprise | +31.32% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 11, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1280776/000128077626000018/vtl-20260630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 11, 2026 | −$1.16 | −$0.80 | 31.32% | — | — |
| Q2 2025 | Aug 7, 2025 | −$1.58 | −$2.00 | -26.74% | — | — |
| Q1 2025 | May 15, 2025 | −$2.40 | −$2.50 | -4.17% | — | — |
| Q4 2024 | Mar 31, 2025 | −$2.35 | −$2.50 | -6.38% | — | — |
| Q3 2024 | Nov 7, 2024 | −$2.18 | −$2.40 | -9.89% | $6,000.00 | — |
| Q2 2024 | Aug 8, 2024 | −$2.33 | −$2.10 | 9.68% | — | — |
| Q1 2024 | May 8, 2024 | −$2.60 | −$3.00 | -15.38% | — | — |
| Q4 2023 | Feb 22, 2024 | −$5.13 | −$4.80 | 6.34% | — | — |
| Q3 2023 | Nov 14, 2023 | −$5.48 | −$5.10 | 6.85% | — | — |
| Q2 2023 | Aug 3, 2023 | −$5.25 | −$5.40 | -2.86% | — | — |
| Q1 2023 | May 11, 2023 | −$5.18 | −$5.80 | -12.08% | — | — |
| Q4 2022 | Feb 23, 2023 | −$7.33 | −$16.30 | -122.53% | — | — |
| Q3 2022 | Nov 3, 2022 | −$6.70 | −$6.90 | -2.99% | — | — |
| Q2 2022 | Aug 4, 2022 | −$7.32 | −$7.20 | 1.64% | — | — |
| Q1 2022 | May 10, 2022 | −$8.09 | −$7.40 | 8.48% | — | — |
| Q4 2021 | Feb 24, 2022 | −$7.66 | −$7.20 | 6.04% | — | — |
| Q3 2021 | Nov 4, 2021 | −$8.05 | −$7.60 | 5.59% | — | — |
| Q2 2021 | Aug 6, 2021 | −$6.84 | −$8.20 | -19.93% | — | — |
| Q1 2021 | May 6, 2021 | −$6.95 | −$16.30 | -134.53% | — | — |
| Q4 2020 | Feb 26, 2021 | −$6.82 | −$4.20 | 38.42% | — | — |

## Frequently Asked Questions

### When did Immunic (IMUX) last report earnings?

Immunic last reported on Aug 11, 2026, covering fiscal Q2 2026.

### Did IMUX beat earnings estimates?

Yes. Immunic reported EPS of −$0.80 for Q2 2026 against a −$1.16 estimate — a 31.32% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).